KILITCH DRUGS (INDIA)
Back to Income Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹198 Cr | ₹167 Cr | ₹130 Cr | ₹122 Cr | ₹104 Cr |
What is the latest Total Expenditure of KILITCH DRUGS (INDIA) ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹198 Cr |
| Mar2025 | ₹167 Cr |
| Mar2024 | ₹130 Cr |
| Mar2023 | ₹122 Cr |
| Mar2022 | ₹104 Cr |
How is Total Expenditure of KILITCH DRUGS (INDIA) Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹198 Cr | 18.95 | |
| Mar2025 | ₹167 Cr | 28.03 | |
| Mar2024 | ₹130 Cr | 6.76 | |
| Mar2023 | ₹122 Cr | 17.48 | |
| Mar2022 | ₹104 Cr | - | |
Compare Total Expenditure of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹642.4 Cr | 8.1% | -5.3% | 3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,236.0 Cr | -1.9% | -3.7% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 2.6% | 11.1% | 56% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 0.2% | 1.3% | 38% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | -1.5% | -6.4% | -12.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1% | -5.1% | -8.1% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 8.1% |
-5.3% |
3.9% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses